Participants who received a COVID-19 vaccine by Moderna have developed antibodies against the virus.
That's according to a press release by the biotech company.
Participants who received a COVID-19 vaccine by Moderna have developed antibodies against the virus.
That's according to a press release by the biotech company.
Researchers working on a vaccine for the novel coronavirus have announced promising results in a very small drug trial. Biotech..